AEMS Corp.

4 Investors
Pharmaceutical formulation
Denver, CO

AEMS Corp. is an innovative company based in Livermore, California that specializes in overcoming intricate drug formulation challenges, particularly those related to viscosity. By optimizing formulation processes, AEMS empowers pharmaceutical companies to expedite the development of new therapies toward market approval.

Products & Team

Advanced Formulation Optimization

Pharmaceutical servicesSeed

AEMS Corp. provides advanced formulation optimization services that assist pharmaceutical companies in navigating complex viscosity challenges. This service utilizes proprietary methods and patented technologies to enhance the formulation process effectively.

Value Proposition

By addressing viscosity challenges early in development, AEMS enables pharmaceutical companies to minimize risk and drive drug candidates through clinical trials more efficiently.

Pain Points

Development programs that are stalled due to formulation complexities and the need for informed decision-making to minimize costs and accelerate timelines.

Early-stage viscosity insights for formulation decisionsExpertise in chemical space mapping to predict ingredient interactionsAccelerated drug development reducing trial-and-error reliance
Industry
Other Technology
Primary business sector
Founded
2025
Year established
Location
Denver, CO
Primary headquarters

Funding History

Total Raised:
$225.0K
E

Equity, Debt Financing Offering

May 2025
$500.0K
Target
Use of Proceeds
OFFICERS TO BE REMUNERATED IN THE ORDINARY COURSE OF BUSINESS
Progress
45%
Raised
$225.0K
Target
$500.0K
#000181916025000002